0001493152-26-009155
SEC filingCuranex Pharmaceuticals Inc entered into employment agreements effective March 1, 2026, with CEO and President Jun Liu (annual base salary $393,600, 3-year term) and COO Dr. Liqin Xie (annual base salary $180,000, at-will employment), formalizing their prior uncompensated or partially compensated service and including equity eligibility, benefits, severance provisions, and restrictive covenants.